Which medication is the first-line treatment for trigeminal neuralgia?

Which medication is the first-line treatment for trigeminal neuralgia?

• A. Carbamazepine
• B. Gabapentin
• C. Amitriptyline
• D. Lamotrigine

Answer: (A)

Trigeminal neuralgia causes sudden, severe, brief facial pain bursts, and controlling those paroxysms most effectively relies on a drug that strongly reduces hyperexcitability of the trigeminal nerve. Carbamazepine does exactly that by blocking voltage-gated sodium channels in nerve membranes, which slows the firing of overactive neurons during an attack. This dampening of abnormal electrical activity translates into faster and more reliable pain relief for many patients, and it is supported by the strongest clinical evidence among pharmacologic options for this condition. Because of this solid efficacy, carbamazepine is routinely chosen as the first medication to try. Starting at a low dose (for example, a small amount taken twice daily) and gradually increasing helps minimize adverse effects while finding the dose that controls pain. Common side effects include drowsiness, dizziness, ataxia, and hyponatremia, with rare but serious risks like severe skin reactions in certain populations, so monitoring is important. Other drugs—gabapentin, amitriptyline, and lamotrigine—can be used for neuropathic pain or adjunctive therapy, but they do not have the same level of evidence or consistent efficacy as first-line therapy for trigeminal neuralgia, which is why they aren’t considered the primary choice.

Trigeminal neuralgia causes sudden, severe, brief facial pain bursts, and controlling those paroxysms most effectively relies on a drug that strongly reduces hyperexcitability of the trigeminal nerve. Carbamazepine does exactly that by blocking voltage-gated sodium channels in nerve membranes, which slows the firing of overactive neurons during an attack. This dampening of abnormal electrical activity translates into faster and more reliable pain relief for many patients, and it is supported by the strongest clinical evidence among pharmacologic options for this condition.

Because of this solid efficacy, carbamazepine is routinely chosen as the first medication to try. Starting at a low dose (for example, a small amount taken twice daily) and gradually increasing helps minimize adverse effects while finding the dose that controls pain. Common side effects include drowsiness, dizziness, ataxia, and hyponatremia, with rare but serious risks like severe skin reactions in certain populations, so monitoring is important.

Other drugs—gabapentin, amitriptyline, and lamotrigine—can be used for neuropathic pain or adjunctive therapy, but they do not have the same level of evidence or consistent efficacy as first-line therapy for trigeminal neuralgia, which is why they aren’t considered the primary choice.